First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval – Lemtrada now available in the U.S. two weeks post [...]
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis Tuesday, November [...]
Study on Abnormal MRIs and the Risk of Developing MS Featured in the International Journal of MS Care (Hackensack, NJ, October [...]
Employment in Multiple Sclerosis (MS) Study Multiple sclerosis (MS), the leading cause of neurological disability among young and [...]
Novartis teams up with multiple sclerosis advocate and musician David Osmond to launch MS education initiative Our Voice in Song™ [...]
New International Survey Finds MS Patients and Neurologists View Communication Positively, Yet Struggle to Discuss Key MS [...]
